The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage
Open accessAbstract
Hypertension, a remediable risk factor for stroke, cardiovascular disease, and renal failure, affects 50 million individuals in the United States alone. African Americans (blacks) have a higher incidence and prevalence of hypertension and hypertension-associated target organ damage compared with Caucasian Americans (whites). Herein, we explored the hypotheses that transforming growth factor-beta(1) (TGF-beta(1)) is hyperexpressed in hypertensives compared with normotensives and that TGF-beta(1) overexpression is more frequent in blacks compared with whites. These hypotheses were stimulated by our recent demonstration that TGF-beta(1) is hyperexpressed in blacks with end-stage renal disease compared with white end-stage renal disease patients and by the biological attributes of TGF-beta(1), which include induction of endothelin-1 expression, stimulation of renin release, and promotion of vascular and renal disease when TGF-beta(1) is produced in excess. TGF-beta(1) profiles were determined in black and white hypertensive subjects and normotensive controls and included circulating protein concentrations, mRNA steady-state levels, and codon 10 genotype. Our investigation demonstrated that TGF-beta(1) protein levels are highest in black hypertensives, and TGF-beta(1) protein as well as TGF-beta(1) mRNA levels are higher in hypertensives compared with normotensives. The proline allele at codon 10 (Pro(10)) was more frequent in blacks compared with whites, and its presence was associated with higher levels of TGF-beta(1) mRNA and protein. Our findings support the idea that TGF-beta(1) hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
Newton, C. R., Graham, A., Heptinstall, L. E., Powell, S. J., Summers, C., Kalsheker, N., Smith, J. C., & Markham, A. F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2503 · Cited by 2,475
Transforming growth factor beta
(2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,944
Human blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C., Flack, J., Frohlich, E. D., Hill, M., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,591
Rosamond, W. D., Folsom, A. R., Chambless, L. E., Wang, C.-H., McGovern, P. G., Howard, G., Copper, L. S., & Shahar, E. (1999) · Stroke · doi:10.1161/01.str.30.4.736 · Cited by 811
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Awad, M. R., El-Gamel, A., Hasleton, P., Turner, D. M., Sinnott, P. J., & Hutchinson, I. V. (1998) · Transplantation · doi:10.1097/00007890-199810270-00009 · Cited by 638
End-stage renal disease in African-American and white men. 16-year MRFIT findings
Klag, M. J. (1997) · JAMA · doi:10.1001/jama.277.16.1293 · Cited by 612
Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B., & Roberts, A. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68561-8 · Cited by 601
Isaka, Y., Fujiwara, Y., Ueda, N., Kaneda, Y., Kamada, T., & Imai, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116874 · Cited by 529
Current protocols in human genetics
Bates, G. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89147-7 · Cited by 482
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
GENETIC ANALYSIS OF PROTEIN EXPORT IN ESCHERICHIA COLI K12
Benson, S. A., Hall, M. N., & Silhavy, T. J. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.000533 · Cited by 428
Strehlau, J., Pavlakis, M., Lipman, M., Shapiro, M., Vasconcellos, L., Harmon, W., & Strom, T. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.695 · Cited by 424
Kurihara, H., Yoshizumi, M., Sugiyama, T., Takaku, F., Yanagisawa, M., Masaki, T., Hamaoki, M., Kato, H., & Yazaki, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92270-5 · Cited by 417
Nabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., & Derynck, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10759 · Cited by 380
Cambien, F., Ricard, S., Troesch, A., Mallet, C., Générénaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., & Poirier, O. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.881 · Cited by 363
Ohno, M., Cooke, J. P., Dzau, V. J., & Gibbons, G. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117787 · Cited by 359
Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients
Perry, H. M., Miller, J. P., Fornoff, J. R., Baty, J. D., Sambhi, M. P., Rutan, G., Moskowitz, D. W., & Carmody, S. E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.587 · Cited by 347
Growth regulatory properties of endothelins
Battistini, B., Chailler, P., D'Orléans-Juste, P., Brière, N., & Sirois, P. (1993) · Peptides · doi:10.1016/0196-9781(93)90057-n · Cited by 334
Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen
Villarreal, F. J., & DILLMANN, W. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.6.h1861 · Cited by 320
Renal Insufficiency in Treated Essential Hypertension
Rostand, S. G., Brown, G., Kirk, K. A., Rutsky, E. A., & Dustan, H. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201102 · Cited by 249
Racial Differences in Plasma Endothelin-1 Concentrations in Individuals With Essential Hypertension
Ergul, S., Parish, D. C., Puett, D., & Ergul, A. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.652 · Cited by 215
Akagi, Y., Isaka, Y., Arai, M., Kaneko, T., Takenaka, M., Moriyama, T., Kaneda, Y., Ando, A., Orita, Y., Kamada, T., et al. (1996) · Kidney International · doi:10.1038/ki.1996.297 · Cited by 200
Takahashi, N., Calderone, A., Izzo, N. J., Mäki, T. M., Marsh, J. D., & Colucci, W. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117485 · Cited by 196
IN VIVO EXPRESSION OF TRANSFORMING GROWTH FACTOR-??1 IN HUMANS: Stimulation by Cyclosporine1
Shin, G.-T., Khanna, A., Ding, R., Sharma, V. K., Lagman, M., Li, B., & Suthanthiran, M. (1998) · Transplantation · doi:10.1097/00007890-199802150-00003 · Cited by 190
Self-citationGrowth factor expression in aorta of normotensive and hypertensive rats.
Sarzani, R., Brecher, P., & Chobanian, A. V. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114029 · Cited by 188
TGF-β 1 DNA Polymorphisms, Protein Levels, and Blood Pressure
Li, B., Khanna, A. K., Sharma, V., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.271 · Cited by 150
Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients
Suthanthiran, M., Khanna, A. K., Cukran, D., Adhikarla, R., Sharma, V. K., Singh, T., & August, P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00858.x · Cited by 86
Self-citationEpidemiology of hypertension in African Americans.
Lackland, D. T., & KEIL, J. E. (1996) · PubMed · Cited by 58
Porreca, E., Febbo, C. D., Mincione, G., Reale, M., Baccante, G., Guglielmi, M. D., Cuccurullo, F., & Colletta, G. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.134 · Cited by 53
Saltis, J., Agrotis, A., & Bobik, A. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02595.x · Cited by 41
Blood pressure variation in blacks: genetic factors.
Grim, C. E., & Robinson, M. (1996) · PubMed · Cited by 39
Agrotis, A., Saltis, J., & Bobik, A. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02484.x · Cited by 11
Cited by
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Metadata
- Authors
- Suthanthiran, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-03-21
- Volume
- 97
- Issue
- 7
- Pages
- 3479-3484
- ISSN
- 0027-8424 (ISSN-L)
- OpenAlex
- W1978863459
- Cited by
- 281
- References
- 36
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.